Literature DB >> 23279686

Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.

Carolin Zschoche, Mona Bidier, Eva Hadaschik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23279686     DOI： 10.1111/ddg.12027

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  3 in total

Review 1.  TNFα inhibitor biosimilars associated with alopecia areata. Case-based review.

Authors:  E Pelechas; P V Voulgari; A A Drosos
Journal:  Rheumatol Int       Date:  2022-04-16       Impact factor: 2.631

Review 2.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

3.  Alopecia universalis during treatment with leflunomide and adalimumab - case report.

Authors:  Rosana Lazzarini; Gabriela Cunha Capareli; Roberta Buense; Rute Facchini Lellis
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.